Impact of High Deductible Health Plans on Continuous Buprenorphine Treatment for Opioid Use Disorder-Reference-Cited by-同舟云学术

Impact of High Deductible Health Plans on Continuous Buprenorphine Treatment for Opioid Use Disorder

Published:2021-08-17 Issue: Volume: Page:
ISSN:0884-8734
Container-title:Journal of General Internal Medicine
language:en
Short-container-title:J GEN INTERN MED

Author:

Kennedy-Hendricks Alene^ORCID,Schilling Cameron J.,Busch Alisa B.,Stuart Elizabeth A.,Huskamp Haiden A.,Meiselbach Mark K.,Barry Colleen L.,Eisenberg Matthew D.

Funder

National Institute on Drug Abuse

Publisher

Springer Science and Business Media LLC

Subject

Internal Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11606-021-07094-9.pdf

Reference42 articles.

1. National Academies of Sciences Engineering and Medicine. Medications for Opioid Use Disorder Save Lives. Washington: The National Academies Press; 2019. doi:https://doi.org/10.17226/25310

2. Connery HS. Medication-Assisted Treatment of Opioid Use Disorder. Harv Rev Psychiatry. 2015;23(2):63-75. doi:https://doi.org/10.1097/HRP.0000000000000075

3. Connery HS, Weiss RD. Discontinuing buprenorphine treatment of opioid use disorder: What do we (not) know? Am J Psychiatry. 2020;177(2):104-106. doi:https://doi.org/10.1176/APPI.AJP.2019.19121245

4. Mattick R, Breen C, Kimber J, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2014 6(2):CD002207. https://doi.org/10.1002/14651858.CD002207.pub4

5. Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. 2009;3:CD002209. doi:https://doi.org/10.1002/14651858.CD002209.pub2

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changes in Healthcare Spending Attributable to High Deductible Health Plan Offer Among Enrollees with Comorbid Substance Use Disorder and Cardiovascular Disease;Journal of General Internal Medicine;2024-03-08

2. Use of in-network insurance benefits is critical for improving retention in telehealth-based buprenorphine treatment;Health Affairs Scholar;2024-01-30

3. Impact of High Deductible Health Plans on U.S. Adults With Chronic Pain;American Journal of Preventive Medicine;2023-11

4. Choice of high-deductible health plans among enrollees with a substance use disorder;Journal of Substance Use and Addiction Treatment;2023-11

5. High-Deductible Health Plans’ Impact on Mental Health and Substance Use Disorder Treatments—Balancing Cost and Care;JAMA Psychiatry;2023-10-01